Originally published In Press as doi:10.1074/jbc.M007093200 on September 11, 2000
J. Biol. Chem., Vol. 275, Issue 49, 38813-38822, December 8, 2000
The Role of the Membrane-spanning Domain of Type I Signal
Peptidases in Substrate Cleavage Site Selection*
Joseph L.
Carlos
§,
Mark
Paetzel¶
,
Greg
Brubaker
,
Andrew
Karla
§,
Christopher M.
Ashwell**,
Mark O.
Lively**
,
Guoqing
Cao
,
Patrick
Bullinger
, and
Ross E.
Dalbey
§§
From the
Department of Chemistry, Ohio State
University, Columbus, Ohio 43210, the ¶ Department of Biochemistry
and Molecular Biology, University of British Columbia, Vancouver,
British Columbia V6T 1Z3, Canada, and ** Wake Forest University School
of Medicine, Winston-Salem, North Carolina 27157
Received for publication, August 6, 2000, and in revised form, September 5, 2000
 |
ABSTRACT |
Type I signal peptidase (SPase I) catalyzes the
cleavage of the amino-terminal signal sequences from preproteins
destined for cell export. Preproteins contain a signal sequence with a positively charged n-region, a hydrophobic h-region, and a neutral but
polar c-region. Despite having no distinct consensus sequence other
than a commonly found c-region "Ala-X-Ala" motif
preceding the cleavage site, signal sequences are recognized by SPase I with high fidelity. Remarkably, other potential
Ala-X-Ala sites are not cleaved within the
preprotein. One hypothesis is that the source of this fidelity is due
to the anchoring of both the SPase I enzyme (by way of its
transmembrane segment) and the preprotein substrate (by the h-region in
the signal sequence) in the membrane. This limits the enzyme-substrate
interactions such that cleavage occurs at only one site. In this work
we have, for the first time, successfully isolated Bacillus
subtilis type I signal peptidase (SipS) and a truncated version
lacking the transmembrane domain (SipS-P2). With purified full-length
as well as truncated constructs of both B. subtilis and
Escherichia coli (Lep) SPase I, in vitro specificity studies indicate that the transmembrane domains of either
enzyme are not important determinants of in vitro cleavage fidelity, since enzyme constructs lacking them reveal no alternate site
processing of pro-OmpA nuclease A substrate. In addition, experiments with mutant pro-OmpA nuclease A substrate constructs indicate that the h-region of the signal peptide is also not critical for substrate specificity. In contrast, certain mutants in the c-region
of the signal peptide result in alternate site cleavage by both Lep and
SipS enzymes.
 |
INTRODUCTION |
Proteins that are exported across the bacterial cell membrane
generally contain amino-terminal signal peptides that are cleaved during translocation of the exported protein across the lipid bilayer.
Cleavage of these signal peptides is accomplished by type I signal
peptidases (SPase I).1 Since
these enzymes are essential for the viability of bacteria (1-4), they
are currently of interest as possible targets for the design of novel
antibiotics (2).
Type I signal peptidases belong to a class of serine proteases that
appear to utilize a serine/lysine dyad mechanism rather than the
serine/histidine/aspartic acid catalytic triad seen in the more
classical serine proteases (5). The most thoroughly studied type I
signal peptidase is the Gram-negative Escherichia coli
signal peptidase (or leader peptidase (Lep)) (6). Unlike E. coli, which contains only one chromosomal copy of Lep, the Gram-positive Bacillus subtilis contains five chromosomal
(SipS, SipT, SipU, SipV, and SipW) and two plasmid-encoded type I
signal peptidases (SipP (pTA1015) and SipP (pTA1040) (7)). The B. subtilis SPases SipS, SipT, SipU, and SipV, which maintain the sequence similarity to the E. coli paralog, are much smaller
in size, contain only one transmembrane anchor instead of two, and have
a much smaller predicted
-sheet domain II than the E. coli enzyme (8). Five of the 30 conserved residues within signal peptidase of B. subtilis (SipS; 21 kDa, 184 amino
acids) have been found to be critical for enzyme function (9, 10).
Arg84 and Asp146 appear to be conformational
determinants, while Ser43, Lys83, and
Asp153 are required for activity. Ser43 is the
putative nucleophile, while Lys83 is believed to act as the
general base in the catalytic mechanism of SipS.
Except for residues involved in catalysis, there has been little work
on the in vitro characteristics of purified SPases other than E. coli Lep. We report in this study the in
vitro characterization of the Gram-positive B. subtilis
type I SPase, SipS, and compare its substrate specificity with
Gram-negative E. coli type I SPase, Lep. We find that some
mutated variants of PONA are better substrates with SipS, whereas these
same mutant preprotein substrates are poorer substrates for E. coli Lep. In addition, we find that transmembrane anchoring of the
SPase I enzyme is not essential for the recognition of the correct
"Ala-X-Ala" cleavage site in the PONA substrate. Using
wild type and mutated variants of PONA, we find that truncated constructs of E. coli Lep or B. subtilis SipS are
still able to maintain substrate specificity and cleave at the proper
cleavage site. With respect to the signal sequence of the preprotein
substrate PONA, our in vitro specificity studies also show
that the h-region is not important for cleavage accuracy. In contrast
to the effects of some mutations in the c-region of the signal peptide,
no h-region changes resulted in altered cleavage site specificity for
either the E. coli or B. subtilis enzymes.
 |
EXPERIMENTAL PROCEDURES |
Cloning of the WT and P2 Domain of SipS--
Mutagenic
oligonucleotides were synthesized by the DNA core facility of the
Comprehensive Cancer Center of Wake Forest University or were purchased
from Integrated DNA Technologies.
Isopropyl-
-D-thiogalactopyranoside, phenylmethanesulfonyl fluoride, ampicillin, and other chemical reagents
were purchased from Fisher. Enzymes for recombinant DNA methods were
purchased from Promega unless stated otherwise. The SipS gene from the
B. subtilis genome was amplified by the polymerase chain
reaction. The strain (8G5sipS; trpC2 try his nic ura met ada sipS) was
obtained from the Ohio State University stock. Polymerase chain
reaction was run for 30 cycles (94 °C for 30 s, 55 °C for 1 min, and 72 °C for 2 min) in a PerkinElmer Life Sciences/Cetus thermal cycler with the sense primer (ACT GGA GGA GAT ATC
ATC AAA TCA GAA AAT GTT) and an antisense primer (GGA AGC TGC TGG
ATC CTA ATT TGT TTT GCG CAT for the SipS WT. The underlined
sequences are the EcoRV and BamHI restriction
sites, respectively. The sense primer for the SipS-P2 construct was CTT
GCT TTG GAT ATC CGC AAC TTT ATT TTT. The polymerase chain
reaction fragments were cut with EcoRV and BamHI
and then ligated in frame into the XmnI and BamHI
restriction sites of the pMAL-c2 expression vector (New England
Biolabs) containing the inducible Ptac promoter. Ligations were
transformed into E. coli host TB1, ara
(lac
proAB) rpsL (
80 lacZ
M15) hsdR. DNA manipulations were performed
as described by Maniatis et al. (11). The cloning procedures
used T4 DNA ligase and restriction enzymes from Life
Technologies, Inc.
Expression and Purification of the MBP-SipS
Fusions--
E. coli (TB1) containing the
pMAL-c2 vector with the SipS gene was grown in Luria-Bertani medium
containing 100 mg/liter ampicillin. Each liter of medium was inoculated
with 10 ml of the overnight cell culture. The cells were grown at
37 °C to a cell density A600 = 0.7, at which
time isopropyl-
-D-thiogalactopyranoside was added to
induce the expression of the fusion protein. The cells were allowed to
grow for an additional 4 h and then harvested by centrifugation
(5000 × g for 5 min, 4 °C). The cells were then resuspended in lysis buffer (10 mM
Na2HPO4, 1.0 mM
phenylmethanesulfonyl fluoride, 30 mM NaCl, 0.07%
-mercaptoethanol, 10 mM EDTA, 10 mM EGTA, pH
7.0) and then lysed by passing them five times through a French
pressure cell at 16,000 p.s.i. The lysate was centrifuged (27,000 × g for 30 min, 4 °C) and the supernatant was diluted 1:5 with 20 mM Tris-HCl, pH 7.4, and then applied to an
amylose resin affinity column (New England Biolabs, 2.5 × 10 cm)
at a flow rate of 1 ml/min. The column was then washed with two column volumes of 20 mM Tris-HCl, pH 7.4. The fusion protein was
eluted with 20 mM Tris-HCl, pH 7.4, containing 10 mM maltose. Fractions were collected and analyzed for
protein by the Bradford method (12). MBP-SipS-P2 fusion protein was
further purified on a Bio-Gel HTP hydroxyapatite column (1.5 × 10 cm) using a gradient elution scheme of 10-500 mM potassium
phosphate, pH 7.4. The fusion proteins were dialyzed extensively
(2 × 9 liters) against 20 mM Tris-HCl, pH 7.4, and
then stored frozen at
70 °C.
Cleavage of the MBP-SipS WT Fusion Protein--
The MBP-SipS WT
fusion protein construct contains a factor Xa cleavage site located
immediately prior to the amino terminus of the SipS protein. Our
preliminary studies indicated that factor Xa cleaves the MBP-SipS WT
fusion very slowly (approximately only 50% cleavage in 2-3 days at
room temperature). Since the factor Xa cleavage site ended with an
arginine, we developed a limited trypsin (Sigma) digest procedure to
cleave the MBP-SipS fusions using 0.1% weight of trypsin/weight of
fusion for 1 h (13). After an optimal digestion time (~20-60
min), as determined individually from small scale experiments of each
purification, the trypsin activity was inhibited using
phenylmethanesulfonyl fluoride and trypsin inhibitor bound to agarose
beads (Sigma).
Cleavage of the MBP-SipS-P2 Fusion Protein--
The MBP-SipS-P2
fusion protein was cleaved using factor Xa. The fusion protein was
incubated at room temperature for 18 h using 2.2 µg of factor
Xa/mg of MBP-SipS-P2 fusion in 50 mM Tris-HCl, pH 8.0, 100 mM NaCl, and 2 mM CaCl2. The factor
Xa cleavage reaction was stopped by the addition of
1,5-dansyl-Glu-Gly-Arg chloromethyl ketone dihydrochloride from Calbiochem.
Purification of SipS and SipS-P2 from MBP--
The SipS (WT)
enzyme was separated from the cleaved MBP by applying the protein to an
Amersham Pharmacia Biotech FF Q Sepharose anion exchange column
(1.5 × 5 cm), which was equilibrated with 20 mM
Tris-HCl, pH 7.4. SipS was then eluted with a 100-700 mM NaCl gradient. Fractions containing pure SipS protein were pooled and
dialyzed against 20 mM Tris-HCl, pH 7.4, and then stored at
70 °C. The SipS-P2 protein was separated from the cleaved MBP by a
Bio-Gel HTP hydroxyapatite column (1.5 × 10 cm) using a gradient of 10-500 mM potassium phosphate, pH 7.4.
Purification of WT Lep and
2-75 Enzymes--
WT (Lep) and
truncated (
2-75) E. coli type I signal peptidase enzymes
were purified as described previously (14, 15).
Isoelectric Focusing of SipS--
One µg of SipS WT was loaded
onto an isoelectric focusing gel using the Amersham Pharmacia Biotech
Phast Gel system, Phast gel 3-9 media, and Amersham Pharmacia Biotech
broad range pI standards (0.2 µg of standard was applied to the gel).
The gel was visualized by Phast Gel Blue R Coomassie staining.
Mass Spectral Analysis--
Purified SipS, SipS-P2, and
substrate PONA masses were confirmed by electrospray ionization mass
spectrometry using a MicroMass VG Quattro II mass spectrometer and a
Finnigan LC Q classic ion trap mass spectrometer.
Cloning, Mutagenesis, and Purification of the Pro-OmpA Nuclease
A--
The coding sequence for the pro-OmpA nuclease A substrate, a
hybrid of the staphylococcal nuclease A fused to the signal peptide of
outer membrane protein A (OmpA), was excised from pONF1 (16) by
digestion with XbaI and SalI and ligated into
pET21a(+) (Novagen) that had been previously digested with
XbaI and XhoI to produce the pETON2 T7
expression vector. Mutagenesis of the pETON2 vector was performed using
the "Mega-primer" method (17) and the QuikChange system
(Stratagene). The complete open reading frame for each mutant was
sequenced by fluorescent dye termination using a PerkinElmer Life
Sciences/Applied Biosystems model 377 automated DNA sequencer. The wild
type and mutant overexpressed pro-OmpA nuclease A proteins were
purified as described by Chatterjee et al. (18). The
His6-tagged PONA mutants were also prepared as
described by Chatterjee et al. except with the substitution
of a nickel chelate affinity step for the final ion exchange
chromatography step. In this final step, His6 PONA extract
was loaded onto a 1-ml bed volume Ni2+-nitrilotriacetic
acid-agarose (Qiagen, Inc.) column and eluted with a stepwise 100-500
mM imidazole gradient.
Activity and Kinetic Analyses Using PONA--
To determine the
kinetic constants (kcat, Km)
of SipS, we used the preprotein substrate pro-OmpA nuclease A. Substrate concentrations were determined by using an
E1% at 280 nm of 8.3 (18). The cleavage
reaction (75 µl) was in 50 mM Tris, 10 mM
CaCl2, 1% Triton X-100, pH 8.0, with the substrate at five different concentrations (37.3, 24.9, 18.7, 12.4, and 6.2 µM). The reaction was initiated by the addition of SipS.
The concentration of SipS as determined by the Pierce BCA protein assay
kit was 0.33 µM. The reaction was carried out at
37 °C, and aliquots of the reaction were removed at various times so
that less than 10% processing of the substrate was achieved. The
reaction was stopped by the addition of 5 µl of 5× sample buffer,
and the samples were frozen immediately in a dry ice/ethanol bath. The
amount of pro-OmpA nuclease A that was processed by SipS was assayed by
SDS-PAGE on a 17.2% gel, followed by staining with Coomassie Brilliant Blue. The precursor and mature proteins were quantified by scanning the
gels on a Technology Resources, Inc. Line Tamer PCLT 300 scanning densitometer. Percentage processing was determined by dividing the area
of the mature protein band by the sum of the mature and precursor band
areas. The initial rates were determined by plotting the amount of
product versus time. The Vmax,
kcat, and Km values were
extracted from a 1/Vi versus
1/[S] plot where Vi is the initial velocity. We used the
computer program Microcal Origins to plot the data and for linear
regression analysis of the data. All values are from at least three
different experiments. The comparisons of the initial rates of
processing of the wild type and mutated variants of PONA by Lep or SipS
enzymes were performed using a constant substrate concentration of 10 µM and a constant enzyme concentration of 10 nM (for the point mutants) or 0.33 µM (for
the more extensive mutations) in 100 mM Tris-HCl, 10 mM CaCl2, pH 8.0, 1% Triton X-100. For each
11-µl reaction volume, 11 µl of 2× dye was added after a 60-min
incubation at 37 °C. Initial velocities were determined by
densitometric quantitation (as above) of 10-µl aliquots taken at
various time points from 84-µl reaction volumes incubated at
37 °C. All reaction samples and time points were run on 17%
SDS-PAGE gels and visualized by Coomassie Blue staining.
Detergent Requirement Studies--
SipS (WT) in 20 mM Tris-HCl, pH 7.4, at 19 µM (400 µg/ml)
was diluted into 20 mM Tris-HCl, pH 7.4, buffer with or
without 0.5% Triton X-100. The reaction was initiated by the addition of 1 µl of each dilution to 10 µl of 20 µM PONA with
or without 0.5% Triton X-100. The reaction was incubated at 37 °C
for 1 h and then stopped by the addition of 2 µl of 5× sample
buffer. The reaction samples were then run on 17% SDS-polyacrylamide
gel and visualized by Coomassie Blue staining.
Amino Acid Sequence Alignment--
The amino acid sequences of
Lep (Swiss-Prot number P00803) and SipS (Swiss-Prot P28628) were
aligned using the program ClustalX (19). Secondary structure-based gap
penalties were used in the profile alignment of the two sequences. The
secondary structure of the soluble fragment of Lep (8) (Protein Data Bank number 1B12) was calculated using the program PROMOTIF (20).
 |
RESULTS |
Active Full-length (SipS) and Truncated (SipS-P2) B. subtilis Type
I Signal Peptidase Were Isolated--
The amino acid sequence
alignment of B. subtilis type I signal peptidase (SipS) as
it compares to E. coli Lep is shown in Fig.
1A. Whereas the 323-amino acid
Lep protein has two transmembrane segments (TM), the
184-amino acid SipS only contains one (Fig. 1A). SipS-P2 is
a SipS deletion mutant construct missing the transmembrane segment
(amino acid residues 2-28). SipS and SipS-P2 were expressed and
purified as maltose-binding protein (MBP) fusions. The amino acid
sequences of the fusion linker region for MBP-SipS and MBP-SipS-P2 are
shown in Fig. 1B. Expressing full-length and truncated
B. subtilis type I signal peptidase as MBP fusions allowed
us to purify 1-mg quantities of the enzyme. We typically
obtained approximately 10 mg of pure fusion protein/liter of cell
culture. Trypsin was used to cleave the WT SipS from the isolated
SipS-MBP fusion protein. On the other hand, because of its higher
susceptibility to trypsin digestion, factor Xa was used to cleave
SipS-P2 from the SipS-P2-MBP fusion protein. Fig.
2, A and C, show
the progression of the purification schemes for SipS and SipS-P2,
respectively. SipS-P2 was further purified using hydroxyapatite
affinity chromatography (not shown). The addition of detergent to the
extraction and purification buffers (1% Triton X-100) did not increase
the yield of full-length SipS with the putative transmembrane domain
(not shown). The purification data in Fig. 2 reflect purification
protocols without the use of any detergents.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 1.
Primary amino acid sequences of E. coli (Lep) and B. subtilis (SipS) type I
signal peptidases. A this alignment is based on the
structure of Lep (8). The secondary structure of Lep is shown
above the sequences. Domain I, the catalytic
domain, is indicated by black secondary
structure, whereas domain II, the extended -ribbon, and C
terminus are indicated by gray secondary
structure. Lep contains two transmembrane segments
(TM), while SipS contains only one. Boxes
A-E represent conserved regions in type I signal peptidases
(6). B, amino acid sequence of the fusion linker region of
the MBP-SipS and MBP-SipS-P2 constructs. The predicted molecular
weights for MBP-SipS and MBP-SipS-P2 are approximately
Mr 63,000 and 60,000, respectively. Shown in
boldface type are amino acids for MBP and the
linker region. The cleavage site for factor Xa is
underlined.
|
|

View larger version (48K):
[in this window]
[in a new window]
|
Fig. 2.
The purification of Bacillus
subtilis type 1 signal peptidase (SipS). A 12%
SDS-polyacrylamide gel shows the purification progression of wild type
SipS (A) and the P2 domain of SipS, SipS-P2 (C).
Also shown are the results from the electrospray mass spectrometry
analysis of purified SipS (B) and purified SipS-P2
(D). Lane M, molecular weight standards;
lane 1, cell lysate before
isopropyl- -D-thiogalactopyranoside induction; lane
2, cell lysate after
isopropyl- -D-thiogalactopyranoside induction; lane
3, purified MBP-SipS (A) and MBP-SipS-P2 (C)
fusion protein from the amylose affinity column; lane 4,
MBP-SipS after trypsin cleavage (A) and after factor Xa
cleavage of MBP-SipS-P2 (C); lane 5, purified
SipS (A) and purified SipS-P2 after anion exchange column
chromatography (C).
|
|
Electrospray ionization mass spectrometry analyses of the purified
protein indicate that we actually have two populations of protein
differing by 2 amino acid residues. In the SipS spectrum (Fig.
2B), two peaks are seen corresponding to the molecular
weights that would be expected if trypsin cleaved at the Arg in the
factor Xa cleavage site and at the Lys2 residue (Fig.
1B). There is an amino-terminal Ile resulting from the
construction of the EcoRV restriction site. For SipS-P2,
however, the molecular weights indicated by electrospray ionization
mass spectrometry (Fig. 2D) indicate that, in addition to
cleavage at the factor Xa site Arg and at Arg30 at the N
terminus (Fig. 1B), cleavage occurs after the sequence -NEMR- at the C terminus of the protein. This results in truncation of
SipS-P2 by 3 amino acids at its C terminus. Factor Xa is known to
recognize the sequences -IEGR-, -IDGR-, and -AEGR- (21), but cleavage
at other similar (secondary) sites is not uncommon (22-24). Because
only two populations of proteins are evident in Fig. 2D for
SipS-P2, cleavage at the C-terminal -NEMR- sequence appears to be
better recognized than the -IEGR- or -RIMK- sequences at the N terminus
of the protein.
Both SipS and SipS-P2 MBP fusion proteins exhibited enzymatic activity
before and after cleavage of the MBP moiety (data not shown). The
engineered linker region (10 Asn residues) probably provides sufficient
flexibility to allow the preprotein substrate access to the SipS active
site (Fig. 1B). After cleavage of the MPB fusion, purified
SipS and SipS-P2 enzymes were able to process purified PONA substrate
in vitro as shown in Fig. 3,
A and Fig. B, respectively. The results indicate
that the SipS-P2 variant is approximately 100-fold less active than
full-length SipS. The kinetic constants of SipS were measured and are
presented alongside the Lep results in Table
I. Purified SipS exhibits a
kcat of 0.034 ± 0.006 s
1 and a Km of 44 ± 10 µM. With this substrate, the B. subtilis
type I signal peptidase (SipS) is approximately 1300-fold less active
than the E. coli leader peptidase. Unfortunately, the much
lower activity of the truncated SipS-P2 enzyme prevented us from
determining its kinetic parameters.

View larger version (53K):
[in this window]
[in a new window]
|
Fig. 3.
The activity and detergent requirement of
purified SipS and SipS-P2 enzymes. A, the processing of
the pro-OmpA nuclease A substrate by serially diluted stock wild type
SipS. B, the processing of the pro-OmpA nuclease A substrate
by serially diluted stock SipS-P2. In A and B,
the 0 dilution lane indicates the no
enzyme added control, and, for each reaction, 1 µl of serially
diluted stock SipS or SipS-P2 enzyme, each at 18 µM
(1 dilution), was added to 10 µl of 20 µM pro-OmpA nuclease A in 20 mM Tris-HCl, pH
7.4. C, serial dilution profile of SipS with 0.5% Triton
X-100. D, serial dilution profile of SipS with no added
detergent. SipS at 0.4 mg/ml was diluted into 20 mM
Tris-HCl, pH 7.4, with (C) or without 0.5% Triton X-100
(D). Each reaction in C and D was
initiated by the addition of 1 µl of each enzyme dilution to 10 µl
of 20 µM pro-OmpA nuclease A substrate with or without
0.5% Triton X-100. After the addition of enzyme, each of the reaction
samples (A-D) were incubated at 37 °C for 1 h and
then stopped by the addition of 2 µl of 5× sample buffer and then
run on 17% SDS-PAGE gels and visualized by Coomassie Blue
staining.
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Comparison of the kinetic constants of SipS with Lep using the
preprotein substrate PONA
The activities were measured at pH 8.0 (see "Experimental
Procedures").
|
|
Interestingly, the activity of full-length SipS, an enzyme with a
transmembrane segment, was only slightly activated by detergent. In a
serial dilution activity profile, we observed only a slight increase
(5-fold) in activity with SipS in the presence of 0.5% Triton X-100
detergent (Fig. 3C). In contrast, we observed approximately a 100-fold stimulation with the E. coli
2-75 (15) using
the same substrate. It also is shown in Fig. 3D that, even
without detergent, full-length SipS exhibits detectable processing of PONA down to a final reaction enzyme concentration of 7 nM
(250-fold dilution lane).
Processing of PONA by E. coli Lep and B. subtilis
SipS at identical cleavage sites was verified by electrospray mass
spectrometry, and the results are shown in Fig.
4. The calculated mass of the full-length
PONA preprotein substrate is 18,839.7 Da, while the mass of the
mature nuclease A fragment after processing at the predicted cleavage
site (after the sequence -FATVAQA-, discussed below) is 16,811.2 Da.
Fig. 4A indicates complete processing of PONA in a 57 µM PONA, 0.074 µM Lep 5-min reaction (TGC
buffer, pH 8.0, 37 °C), resulting in only a mature nuclease A peak
of Mr 16,814.0. Conversely, a 20-min reaction of
57 µM PONA, 0.127 µM SipS results in
detection of both the parent PONA substrate (Mr
18,843.0) and processed nuclease A (Mr 16,813.0)
as shown in Fig. 4B.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 4.
Purified Lep and SipS enzymes cleave pro-OmpA
nuclease A substrate at the same cleavage site. Electrospray mass
spectrum of 0.074 µM Lep (A) or 0.127 µM SipS (B) with 57 µM pro-OmpA
nuclease A substrate incubated for 90 min in 20 mM TGC, 1%
Triton-100, pH 8.0, buffer.
|
|
Disruption of the h-region of the Signal Peptide Substrate Does Not
Perturb SipS Processing--
A series of point mutations in the
n-, h-, and c-region of the signal peptide of PONA were
constructed to determine the effects on processing by B. subtilis SipS. The initial velocities of SipS processing of the
wild type and point mutant PONA substrates are listed in Table
II. SipS processed all of the point
mutant substrates within the same order of magnitude relative to the
wild type substrate. The highest SipS processing occurred with the
V
12A and V
4P mutants. The sequence numbering system is relative to
the cleavage site (i.e. the residues in the signal peptide
are negative, and the numbers in the mature protein are positive). The
K
20D and A+1R mutants were processed with roughly twice the initial
velocity of the wild type PONA substrate. The mutants at the
8
position (G
8A and G
8R) had little effect on the initial rate of
processing. The L
10N mutant was processed at a slightly slower rate
than wild type. As expected, the A
1R and A
3R negative control
mutants displayed no detectable processing by SipS in the time periods assayed (Table II). A rather surprising result was that a double Arg
mutant (V
12R/G
8R) in the h-region of the signal peptide of PONA was
processed by SipS (Table II).
To look closer at the role of the h-region and the c-/h-region boundary
of the signal peptide with respect to E. coli or B. subtilis SPase I processing, other more extensive amino acid
mutants in the signal peptide h- or c-region of the substrate PONA were constructed. The amino acid sequences in the signal peptide region for
each of these mutant variants of purified PONA are listed in Table
III. A comparison of processing by
purified full-length or truncated E. coli SPase I (Lep,
2-75) or B. subtilis SipS (SipS, SipS-P2) enzymes
against these purified PONA mutant proteins are illustrated in Fig.
5. The 6HisPONA construct indicates PONA amended with a hexahistidine tag in the N-terminal region of the signal
peptide. This purified variant of PONA enabled us to use a more rapid
scheme for the purification of the WT form as well as some of the
mutated PONA substrates. There were no differences in
kcat, Km, and specificity
(compared with WT with no His6 tag) resulting from this
insertion at the N terminus of PONA (data not shown). Because of the
different mutations, the masses of each of the starting unprocessed
PONA substrates varied (see No Enzyme added
control gel and upper bands in other gels), but, as shown in Fig. 5, an identical lower molecular weight band (mature nuclease A) is present in all cases where processing was detected. Cleavage of each of the purified mutated PONA substrate variants at the
identical cleavage site as WTPONA (Mr ~16,800
for mature nuclease A) was also verified (as in Fig. 4) by mass
spectrometry (not shown).

View larger version (58K):
[in this window]
[in a new window]
|
Fig. 5.
Processing of WT and mutant PONA by Lep,
2-75, SipS, and SipS-P2. Shown are 17%
SDS-PAGE analyses comparing cleavage of the indicated PONA substrate
constructs by each of the purified enzymes. For each lane, 1 µl of
enzyme was added to 10 µl of the indicated PONA substrate (10 µM substrate and 0.33 µM final enzyme
concentration) and incubated for 1 h at 37 °C in 50 mM Tris-HCl, 10 mM CaCl2, pH 8.0, 1% Triton X-100. See "Experimental Procedures" for additional
details. The arrow (SipS-P2 gel) indicates SipS-P2 enzyme
(Mr ~17,400). The asterisk
indicates alternate cleavage of A15PONA, resulting in the additional
higher molecular weight band (Mr 18,080 as
verified by mass spectrometry).
|
|
The Membrane-spanning Domains of B. subtilis or E. coli SPase I Are
Not Required for Cleavage Site Specificity--
One of the more
significant results in the comparisons of B. subtilis
versus E. coli SPase I processing of the
extensive PONA signal sequence mutants is that obtained with the
truncated enzymes. Although the processing by truncated enzyme
constructs,
2-75 or SipS-P2, of wild type (or WT-His6)
PONA is slightly less efficient than with the full-length enzymes, it
is shown in Fig. 5 (lane 1) that substrate
specificity is maintained. Even without their respective transmembrane
regions, these purified catalytic domains of the E. coli and
B. subtilis SPase I enzymes are still able to recognize and
process the substrate at the same cleavage site.
Gln Insertions at the h/c-region Boundary Are More Efficiently
Processed by the B. subtilis Enzyme Constructs--
The Q5 and
Q10-PONA constructs represent 5 and 10 Gln residue insertions,
respectively, to extend the c-region of the signal peptide at the
h-region boundary. Gln was chosen because of its hydrophilic nature,
occurrence in natural signal peptides (25), and low likelihood of
alternate cleavage site introduction (26-28). The PONA signal peptide
Gln amino acid insertion mutants are listed in Table III. The extension
of the signal peptide c-region by 5 or 10 Gln residues resulted in the
maintenance of enzyme specificity (as evidenced by a single processed
band), but SipS or SipS-P2 better tolerated the changes than Lep or
2-75. As seen in Fig. 5, there is greater processing of Q5 or
Q10PONA by either SipS or SipS-P2 (lanes 3 and
4). For illustrative and quantitative purposes, the initial
velocities for Lep,
2-75, SipS, and SipS-P2 processing of the
Q5PONA mutant were determined. As seen in Table IV, the initial velocity ratios indicate
that the Q5PONA mutant is indeed processed more efficiently by the SipS
or SipS-P2 enzymes. With an initial velocity ratio (Lep/SipS) of 0.23, the SipS initial velocity is a little over 4 times greater than the Lep
initial velocity at the conditions tested. Similarly, the truncated
SipS-P2 enzyme is more efficient at processing Q5PONA substrate than
its E. coli counterpart,
2-75, with an initial velocity
ratio of 0.39 (
2-75/SipS-P2).
View this table:
[in this window]
[in a new window]
|
Table IV
Initial velocities (Vi) of purified E. coli
(Lep, 2-75) and B. subtilis (SipS, SipS-P2) signal peptidases using
WTPONA, Q5PONA, and A14PONA substrates
|
|
An Extension of the h-region of the Signal Peptide Does Not Affect
Cleavage Site Selection by SPase I--
The disruption of the h-region
did not affect processing by SipS (Table II). To further examine the
role of the h-region, this domain was extended by 5 and 10 Leu residues
(L5PONA and L10PONA, respectively) as listed in Table III. Leu was
chosen because of its hydrophobic nature, occurrence in natural signal
peptides (25), and low likelihood of alternate cleavage site
introduction (26, 27). Using both the L5PONA and L10PONA substrate
constructs, processing is less efficient compared with WTPONA
(lane 1), but only one cleavage product
(Mr ~16,800) is observed (Fig. 5,
lanes 5 and 6), indicating maintenance
of cleavage at the correct site. No detectable processing is observed,
however, of the L10PONA substrate with the SipS-P2 truncated B. subtilis enzyme. No evidence of alternate site cleavage is
apparent with either of these purified h-region mutants.
In contrast to h-region mutants that had no effect on cleavage site
fidelity, a c-region mutant of the signal peptide of PONA results in
alternate site processing. A random presequence, referred to as A13,
was reported by van Dijl and colleagues (9) to enable efficient
in vivo processing of A13-
-lactamase by both E. coli Lep and B. subtilis SipS. In our study, purified
A14 and A15PONA proteins signify 6 and 10 amino sequence portions,
respectively, of the reported A13 presequence inserted into the
C-terminal region of the signal peptide of PONA substrate (see Table
III). In vitro, as seen in Fig. 5 (lane 7), the
A14PONA mutant substrate, with a six-amino acid insertion (DPLEST),
gives similar results to the Q5PONA and Q10PONA mutants, whereby
processing compared with WTPONA is reduced but cleavage site
specificity is maintained. Initial velocity calculations for the
A14PONA substrate are shown in Table IV. The calculated initial
velocity ratios of 0.72 (Lep/SipS) and 0.07 (
2-75/SipS-P2)
confirmed that the A14PONA substrate is slightly preferred by B. subtilis SipS or SipS-P2. On the other hand, the 10-amino acid
insertion construct (VGSGDPLEST), resulting in the mutant A15PONA,
results in loss of cleavage site specificity and poor processing
efficiency. In vitro processing of A15PONA by Lep,
2-75,
SipS, or SipS-P2 results in two cleavage products as seen in Fig. 5,
lane 8. As verified by mass spectrometry, the higher molecular weight product (Mr ~18,100)
results from cleavage after -AIAIAVALA- in the signal sequence, while
the lower molecular weight product (Mr
~16,800) results from cleavage at the "correct" site (after -DPLESTAQA-).
 |
DISCUSSION |
A soluble MBP-SipS fusion protein was purified in the total
absence of detergent. The analogous E. coli enzyme, Lep, has
two transmembrane regions and it has been found to aggregate and
precipitate out of solution under identical conditions. Unlike
Gram-negative E. coli Lep, the Gram-positive SipS protein
maintained sufficient tolerance to mild trypsin digestion, enabling
rapid cleavage of MBP from the purified fusion protein.
Purified B. subtilis SipS enzyme is able process PONA to
completion (Fig. 3A, 1 dilution) with a
kcat of 0.034 ± 0.006 s
1 and a Km of 44 ± 10 µM (Table I). Although about 100-fold less active than
full-length SipS, the truncated version, SipS-P2, can also process PONA
substrate to completion at higher enzyme concentrations or at longer
incubation periods than the 1-h end point shown in Fig. 3B.
Purified PONA substrate thus provides a readily available in
vitro assay of SipS or SipS-P2 activity. It is interesting that,
at the conditions studied, the ratios of the initial velocities of
full-length to truncated E. coli or B. subtilis
enzymes were similar (Table IV). The Lep/
2-75 and SipS/SipS-P2
initial velocity ratios were 3.17 and 3.40, respectively, indicating
similar losses in cleavage efficiency from the deletion of the
transmembrane regions.
The activity of the purified B. subtilis enzyme, SipS, is
only slightly stimulated by Triton X-100 detergent. This is in contrast to the E. coli
2-75 enzyme that is strongly stimulated
by detergent (15). As shown in Fig. 1A, SipS is missing a
second transmembrane domain and a good portion of a
-sheet domain
found in Lep. This may result in a smaller hydrophobic patch
surrounding the active site of SipS and lead to the lower detergent
requirement observed.
In a scanning mutagenesis approach, point mutations in the signal
peptide of PONA substrate were constructed to see their effect on
processing by SipS enzyme. The rationale for the point mutants listed
in Table II is as follows: A+1R, to see the effect of a positive charge
in the first position of the mature protein; V
4P, to delineate the c-
and h-region boundary, since prolines are typically found in this
region (29, 30); G
8R, L
10N, and V
12R were intended to disrupt the
h-region; K
20D, a negative charge here would neutralize the adjacent
Lys, giving the n-region no net charge overall (a positively charged
n-region is typical of signal peptides (31)); A
1R and A
3R mutants
were intended as noncleavable controls following the previously
reported results of
3 and
1 charged residues preventing processing
(32-35).
As expected, changing the
1 or
3 residue of PONA to arginine
prevented processing of the substrate. No processing was observed at
nearby, potential alternative cleavage sites. This is in contrast to
work on the precursor to the maltose-binding protein, where certain
mutations at the
1 site resulted in processing at an alternative site
(34). Except for G
8A and L
10N, all of these point mutants resulted
in increased processing (as measured by initial velocity) in
vitro by SipS enzyme. The mutations probably result in subtle
changes to the signal peptide conformation of each individual mutant,
thus affecting the interactions with SipS enzyme.
Several interesting results were obtained by studying the substrate
specificity of signal peptidases using the purified full-length and
truncated forms of E. coli Lep and B. subtilis
SipS enzymes. First, we found that a simple tethering of the signal
peptidase catalytic domain by the transmembrane segment is not a major
factor involved in specificity at the
3,
1 cleavage site. This
result was surprising because one compelling hypothesis in the field is
that type I signal peptidase recognition of the "correct" substrate cleavage site occurs because the anchoring of the enzyme by way of its
transmembrane domain limits its mobility. The
3,
1 signal peptidase
cleavage site is typically an Ala-X-Ala motif (36, 37), and
this limitation in mobility of the enzyme results in the recognition of
only the correct Ala-X-Ala site and not other such sites in
the signal peptide or mature region of the substrate. Only one such
cleavage site is recognized on a substrate that is also
membrane-tethered (by the h-region of the signal sequence). This
hypothesis was tested by examining the specificity of truncated versions of E. coli Lep and B. subtilis SipS.
Substrate cleavage at the correct site is maintained with the truncated
enzymes,
2-75 and SipS-P2. In Fig. 5, lane 1, it is
shown that
2-75 and SipS-P2 process WTPONA at the same cleavage
site (after -GFATVAQA-; Table III) as full-length Lep and SipS. For
both the full-length and truncated enzymes, only one (identical) mature
processed band is observed. In all cases, the mature protein was
determined to be Mr ~16,810 by mass
spectrometry. The lack of other processed bands indicates no processing
at alternative cleavage sites. Although less efficient than full-length
enzyme, the truncated enzymes,
2-75 and SipS-P2, still cleave at
the same position and do not recognize other potential cleavage sites
in the presequence or the mature protein.
Second, a longer signal peptide h-domain attached to the substrate does
not necessarily make it a better substrate. One reason to expect this
is that the average Gram-positive signal peptide is 32.0, while the
average Gram-negative signal peptide is 25.1 amino acids in length (38,
39). This greater average length in the Gram-positive species is due in
part to the longer h-regions of the signal peptide. In our studies,
however, the extension of the h-region in the presequence of PONA by 5 and 10 Leu residues did not improve its cleavability by the
Gram-positive B. subtilis enzyme. The insertion of 5 Leu
residues (L5PONA) resulted in overall slower processing by all of the
enzyme constructs studied (Lep,
2-75, SipS and SipS-P2; Fig. 5,
lanes 5 and 6). The insertion of 10 Leu residues (L10PONA)
resulted in a much more severe decrease in processing than L5PONA for
each of the enzymes used. In fact, no processing was detected at all
for processing of L10PONA by SipS-P2 even after an extended overnight
incubation (not shown) at the conditions used for Fig. 5 (1-h
incubation). There were no observed changes in "enzyme preferences"
for these two PONA h-region mutants. Like with WTPONA, there was
greater processing by Lep and
2-75 of L5PONA or L10PONA substrate
than by SipS (or SipS-P2) enzymes (Fig. 5). With respect to
specificity, the signal peptide h-region insertion mutants did not
exhibit any evidence of alternate site cleavage. Both L5PONA and
L10PONA were processed at the same cleavage site as WTPONA substrate.
Third, disruption of the length of the h-domain in the signal peptide
of PONA by Arg substitutions at either the
12 or
8 position
(Tables II and III) did not affect processing. Even the introduction of
both positive charges to obtain the double Arg mutant (Table III),
resulted in a substrate displaying a measurable initial velocity with
SipS (Table II). These results clearly show that the length of the
hydrophobic domain can be shortened without a marked effect on signal
peptide processing by the B. subtilis signal peptidase. This
is surprising in light of recent results by Stein et al.
(40), who showed that the insertion of 10 consecutive leucine residues
into a short fluorogenic peptide substrate (41) resulted in a dramatic
104 increase in
kcat/Km by E. coli
Lep.
Fourth, although the c-regions of Gram-positive bacterial signal
peptides are also typically longer than the c-region of Gram-negative bacterial signal peptides (38, 39), the lengthening of the c-region of
PONA did not improve its efficiency as a substrate for Gram-positive
SipS. In our study, the Q5PONA and Q10PONA constructs were created to
extend the c-region of the signal sequence of PONA by 5 and 10 Gln
residues, respectively (see Table III). No change in cleavage site
specificity was observed, but processing trials of these substrates
indicated that SipS or SipS-P2 more efficiently cleaves them than the
E. coli enzymes. In Fig. 5, lanes 3 and 4, greater processing is observed for the B. subtilis enzyme(s) than the E. coli signal peptidase
for Q5PONA and Q10PONA. Since the results for Q5PONA were more dramatic
than with Q10PONA, the initial velocities were determined for the
Q5PONA substrate mutant (see Table IV). For Q5PONA, the SipS initial
velocity is over four times greater and the SipS-P2 velocity is about
2.5 times greater than the calculated initial velocities for Lep and
2-75, respectively. An extension of the c-region was made to mimic
a portion of the van Dijl sequence reported to be processed by both Lep
and SipS (9). This 6-amino acid insertion of the sequence DPLEST into
the c-region of the presequence of PONA produced a mutant (A14PONA)
with similar cleavage characteristics to the Gln5 insertion
mutant, Q5PONA. Like Q5PONA, the initial velocities of A14PONA
processing are greater for the B. subtilis enzyme constructs than the E. coli enzyme constructs (Fig. 5, lane
7 and Table IV). A further extension of this A14PONA mutant by an
additional 4 residues (to produce A15PONA, which includes more
of the van Dijl A13 presequence) again resulted in a substrate that was
better processed by SipS and SipS-P2, but cleavage at another cleavage site was now apparent with all of the enzymes (Fig. 5, lane
8, asterisk).
The substrate specificity results reported here support a hypothesis of
enzyme-substrate interactions provided by the c-region of the signal
peptide playing an important role in specificity. A simple
Gln5 insertion (Q5PONA) into the c-region appeared to be
even better than a more deliberate 6-residue insertion (A14PONA) in
yielding a substrate more preferred by B. subtilis SipS or SipS-P2 than by either E. coli signal peptidase construct.
With the
3 and
1 residues providing the primary interactions with the enzyme, secondary and perhaps transient interactions during the
course of catalysis are provided by the c-region of the signal peptide.
While we did not have sufficient quantities of Q5PONA substrate to
perform kinetic analyses on it, we were able to determine kinetic
parameters for Lep and SipS processing of the A14PONA mutant. The
kcat, Km, and
kcat/Km values obtained are,
respectively, 0.043 ± 0.003 s
1,
42.5 ± 1.0 µM, and 1.0 × 103
M
1 s
1
for SipS and 0.014 ± 0.003 s
1,
16.6 ± 3.1 µM, and 8.4 × 102
M
1 s
1
for Lep. For both SipS and Lep, the Km values for
A14PONA are similar to WTPONA (see Table I). Thus, assuming that
Km
Kd, the purified signal
peptidases from B. subtilis and E. coli bind the
mutant A14PONA substrate equally as WTPONA. The 6-amino acid sequence
insertion into the c-region of the signal peptide of PONA resulting in
A14PONA results only in a large decrease in kcat
for Lep (no change in Km within error), while the
SipS kinetic parameters are essentially unchanged. The Lep enzyme
experiences a severe drop in catalytic efficiency by at least 3 orders
of magnitude (compare Table I values). These results are consistent
with enzyme-substrate interactions effected by the A14PONA mutations
that are not present in the Michaelis complex. This suggests transient
enzyme-substrate interactions, provided by the c-region of the signal
peptide, that are not present in the ground state enzyme-substrate complex.
In summary, we have purified enzymatically active B. subtilis SPase I, which exhibits activity with the preprotein
substrate, PONA. Mass spectrometry has directly shown that identical
in vitro processing of PONA occurs by two signal peptidases
from different organisms, Gram-positive B. subtilis (SipS)
and Gram-negative E. coli (Lep). Disproving the hypothesis
that the hydrophobic membrane segment(s) of the SPase I enzyme plays a
direct role in determination of the substrate cleavage site, our
experiments show that the Lep and Sips enzymes, lacking their
respective transmembrane domains (
2-75 and SipS-P2, respectively),
retain the same substrate specificity as the parent native enzymes. In
addition, the h-region signal transmembrane anchor of the signal
peptide substrate also is not a factor in cleavage site recognition.
For either enzyme, the disruption or even lengthening of the h-region
of the preprotein substrate only altered the enzyme-substrate
interaction, as evidenced by changes in the rate of cleavage, but the
correct bond was still cleaved. Lengthening the h- or c-region of the
signal peptide of PONA substrate did not make this preprotein a better
substrate despite the statistical evidence of signal peptides in
Gram-positive eubacteria having longer h- and c-regions than
Gram-negative organisms. Based on more experimental evidence, a good
longer term objective is to eventually determine, more precisely, some
of the determinants of specificity for both Gram-positive and
Gram-negative bacteria. Other than the
1 and
3 residues, what are
the specific enzyme-substrate interactions that occur during cleavage
of the substrate? With the isolation of B. subtilis SipS in
sufficient quantities to do physical characterizations, we are now in a
position to attempt to answer questions such as these.
 |
ACKNOWLEDGEMENTS |
Special thanks goes to Don Ordaz at (Ohio
State University Department of Microbiology Bio-fermentation
facilities) and to Mark Schiller for help with the His6
PONA construct.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Supported by National Institutes of Health (NIH) Grant GM 08512.
Supported by a Procter & Gamble 1-year graduate fellowship and
a Medical Research Council of Canada postdoctoral fellowship.

Supported by NIH Grant GM32861.
§§
Supported by American Heart Association Grant-in-Aid 94011570, NIH Grant GM48805, and a gift from SmithKline Beecham Pharmaceutical. To whom all correspondence should be addressed. Tel.: 614-292-2384; Fax: 614-292-1532; E-mail: dalbey@chemistry.ohio-state.edu.
Published, JBC Papers in Press, September 11, 2000, DOI 10.1074/jbc.M007093200
 |
ABBREVIATIONS |
The abbreviations used are:
SPase I, type I
signal peptidase;
SipS, signal peptidases of B. subtilis;
SipS-P2, the fragment of SipS lacking the transmembrane segment;
Lep, E. coli leader peptidase (type I signal peptidase);
WT, wild
type;
MBP, maltose binding protein;
PONA, pro-OmpA nuclease A;
PAGE, polyacrylamide gel electrophoresis.
 |
REFERENCES |
| 1.
|
Date, T.
(1983)
J. Bacteriol.
154,
76-83
|
| 2.
|
Cregg, K. M.,
Wilding, I.,
and Black, M. T.
(1996)
J. Bacteriol.
178,
5712-5718
|
| 3.
|
Zhang, Y. B.,
Greenberg, B.,
and Lacks, S. A.
(1997)
Gene (Amst.)
194,
249-255
|
| 4.
|
Klug, G.,
Jager, A.,
Heck, C.,
and Rauhut, R.
(1997)
Mol. Gen. Genet.
253,
666-673
|
| 5.
|
Paetzel, M.,
and Dalbey, R. E.
(1997)
Trends Biochem. Sci.
22,
28-31
|
| 6.
|
Dalbey, R. E.,
Lively, M. O.,
Bron, S.,
and van Dijl, J. M.
(1997)
Protein Sci.
6,
1129-1138
|
| 7.
|
Tjalsma, H.,
Bolhuis, A.,
van Roosmalen, M. L.,
Wiegert, T.,
Schumann, W.,
Broekhuizen, C. P.,
Quax, W. J.,
Venema, G.,
Bron, S.,
and van Dijl, J. M.
(1998)
Genes Dev.
12,
2318-2331
|
| 8.
|
Paetzel, M.,
Dalbey, R. E.,
and Strynadka, N. C.
(1998)
Nature
396,
186-190
|
| 9.
|
van Dijl, J. M.,
de Jong, A.,
Vehmaanpera, J.,
Venema, G.,
and Bron, S.
(1992)
EMBO J.
11,
2819-2828
|
| 10.
|
van Dijl, J. M.,
de Jong, A.,
Venema, G.,
and Bron, S.
(1995)
J. Biol. Chem.
270,
3611-3618
|
| 11.
|
Maniatis, T.,
Fritsch, E. F.,
and Sambrook, J.
(1982)
Molecular Cloning: A Laboratory Manual
, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 12.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254
|
| 13.
|
Patterson, W. R.,
and Poulos, T. L.
(1994)
J. Biol. Chem.
269,
17020-17024
|
| 14.
|
Klenotic, P. A.,
Carlos, J. L.,
Samuelson, J. C.,
Schuenemann, T. A.,
Tschantz, W. R.,
Paetzel, M.,
Strynadka, N. C.,
and Dalbey, R. E.
(2000)
J. Biol. Chem.
275,
6490-6498
|
| 15.
|
Tschantz, W. R.,
Paetzel, M.,
Cao, G.,
Suciu, D.,
Inouye, M.,
and Dalbey, R. E.
(1995)
Biochemistry
34,
3935-3941
|
| 16.
|
Takahara, M.,
Hibler, D. W.,
Barr, P. J.,
Gerlt, J. A.,
and Inouye, M.
(1985)
J. Biol. Chem.
260,
2670-2674
|
| 17.
|
Sarkar, G.,
and Sommer, S. S.
(1990)
BioTechniques
8,
404-407
|
| 18.
|
Chatterjee, S.,
Suciu, D.,
Dalbey, R. E.,
Kahn, P. C.,
and Inouye, M.
(1995)
J. Mol. Biol.
245,
311-314
|
| 19.
|
Thompson, J. D.,
Gibson, T. J.,
Plewniak, F.,
Jeanmougin, F.,
and Higgins, D. G.
(1997)
Nucleic Acids Res.
25,
4876-4882
|
| 20.
|
Hutchinson, E. G.,
and Thornton, J. M.
(1996)
Protein Sci.
5,
212-220
|
| 21.
|
Nagai, K.,
and Thogersen, H. C.
(1984)
Nature
309,
810-812
|
| 22.
|
Nagai, K.,
Perutz, M. F.,
and Poyart, C.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
7252-7255
|
| 23.
|
Eaton, D.,
Rodriguez, H.,
and Vehar, G. A.
(1986)
Biochemistry
25,
505-512
|
| 24.
|
Wearne, S. J.
(1990)
FEBS Lett.
263,
23-26
|
| 25.
|
von Heijne, G.
(1986)
J. Mol. Biol.
192,
287-290
|
| 26.
|
Laforet, G. A.,
and Kendall, D. A.
(1991)
J. Biol. Chem.
266,
1326-1334
|
| 27.
|
Jain, R. G.,
Rusch, S. L.,
and Kendall, D. A.
(1994)
J. Biol. Chem.
269,
16305-16310
|
| 28.
|
Nilsson, I.,
and von Heijne, G.
(1991)
J. Biol. Chem.
266,
3408-3410
|
| 29.
|
Perlman, D.,
and Halvorson, H. O.
(1983)
J. Mol. Biol.
167,
391-409
|
| 30.
|
Rosenblatt, M.,
Beaudette, N. V.,
and Fasman, G. D.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
3983-3987
|
| 31.
|
von Heijne, G.,
and Abrahmsen, L.
(1989)
FEBS Lett.
244,
439-446
|
| 32.
|
Kuhn, A.,
and Wickner, W.
(1985)
J. Biol. Chem.
260,
15914-15918
|
| 33.
|
Karamyshev, A. L.,
Karamysheva, Z. N.,
Kajava, A. V.,
Ksenzenko, V. N.,
and Nesmeyanova, M. A.
(1998)
J. Mol. Biol.
277,
859-870
|
| 34.
|
Fikes, J. D.,
Barkocy-Gallagher, G. A.,
Klapper, D. G.,
and Bassford, P. J., Jr.
(1990)
J. Biol. Chem.
265,
3417-3423
|
| 35.
|
Shen, L. M.,
Lee, J. I.,
Cheng, S. Y.,
Jutte, H.,
Kuhn, A.,
and Dalbey, R. E.
(1991)
Biochemistry
30,
11775-11781
|
| 36.
|
von Heijne, G.
(1983)
Eur. J. Biochem.
133,
17-21
|
| 37.
|
von Heijne, G.
(1985)
J. Mol. Biol.
184,
99-105
|
| 38.
|
Nielsen, H.,
Engelbrecht, J.,
Brunak, S.,
and von Heijne, G.
(1997)
Int. J. Neural. Syst.
8,
581-599
|
| 39.
|
Nielsen, H.,
Engelbrecht, J.,
Brunak, S.,
and von Heijne, G.
(1997)
Protein Eng.
10,
1-6
|
| 40.
|
Stein, R. L.,
Barbosa, M. D. F. S.,
and Bruckner, R.
(2000)
Biochemistry
39,
7973-7983
|
| 41.
|
Zhong, W.,
and Benkovic, S. J.
(1998)
Anal. Biochem.
255,
66-73
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Fine, V. Irihimovitch, I. Dahan, Z. Konrad, and J. Eichler
Cloning, Expression, and Purification of Functional Sec11a and Sec11b, Type I Signal Peptidases of the Archaeon Haloferax volcanii.
J. Bacteriol.,
March 1, 2006;
188(5):
1911 - 1919.
[Abstract]
[Full Text]
[PDF]
|
 |
|